These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38211367)
1. Effectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation. Dams GM; Ketchen BR; Burden JL; Smith NB Drug Alcohol Depend; 2024 Feb; 255():111081. PubMed ID: 38211367 [TBL] [Abstract][Full Text] [Related]
2. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program. Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264 [TBL] [Abstract][Full Text] [Related]
3. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes. Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579 [TBL] [Abstract][Full Text] [Related]
4. The Individualized Addictions Consultation Team Residential Program: A Creative Solution for Integrating Care for Veterans With Substance Use Disorders Too Complex for Other Residential Treatment Programs. Keating S; Larsen SE; Collingwood J; Smith HM J Dual Diagn; 2021; 17(2):172-179. PubMed ID: 33583351 [TBL] [Abstract][Full Text] [Related]
5. Pilot randomized controlled trial of a brief strategy to prevent suicide after discharge from residential addiction treatment. Kenneally L; Stevens S; Cornelius S; Shiner B; Rice K; Park J; Watts BV; Teja N; Riblet N J Subst Use Addict Treat; 2023 Nov; 154():209156. PubMed ID: 37652208 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders. Painter JM; Brignone E; Gilmore AK; Lehavot K; Fargo J; Suo Y; Simpson T; Carter ME; Blais RK; Gundlapalli AV Psychol Serv; 2018 Feb; 15(1):11-20. PubMed ID: 28517950 [TBL] [Abstract][Full Text] [Related]
7. Integrating comprehensive hepatitis C virus care within a residential substance use disorder treatment program. Burton MJ; Voluse AC; Anthony V J Subst Abuse Treat; 2019 Mar; 98():9-14. PubMed ID: 30665610 [TBL] [Abstract][Full Text] [Related]
8. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions. Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057 [TBL] [Abstract][Full Text] [Related]
10. Outpatient continuing care after residential substance use disorder treatment in the US Veterans Health Administration: Facilitators and challenges. Rubinsky AD; Ellerbe LS; Gupta S; Phelps TE; Bowe T; Burden JL; Harris AHS Subst Abus; 2018; 39(3):322-330. PubMed ID: 29043947 [TBL] [Abstract][Full Text] [Related]
11. Substance Use Relapse Among Veterans at Termination of Treatment for Substance Use Disorders. Betancourt CA; Kitsantas P; Goldberg DG; Hawks BA Mil Med; 2022 Oct; 187(11-12):e1422-e1431. PubMed ID: 34272857 [TBL] [Abstract][Full Text] [Related]
12. Inpatient hospitalization for substance use disorders one year after residential rehabilitation: predictors among US veterans. Chang G; Martin KB; Tang M; Fleming JA Am J Drug Alcohol Abuse; 2016; 42(1):56-62. PubMed ID: 26485005 [TBL] [Abstract][Full Text] [Related]
13. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. Kraemer KL; McGinnis KA; Fiellin DA; Skanderson M; Gordon AJ; Robbins J; Zickmund S; Bryant K; Korthuis PT J Subst Abuse Treat; 2019 Aug; 103():23-32. PubMed ID: 31229189 [TBL] [Abstract][Full Text] [Related]
14. An Analysis of Irregular Discharges From Residential Treatment Programs in the Department of Veterans Affairs Health Care System. Riblet NB; Gottlieb DJ; Shiner B; Zubkoff L; Rice K; Watts BV; Rusch B Mil Med; 2023 Nov; 188(11-12):e3657-e3666. PubMed ID: 37167031 [TBL] [Abstract][Full Text] [Related]
15. Neurocognitive function and medical care utilization in Veterans treated for substance use disorder. Bjork JM; Reisweber J; Perrin PB; Plonski PE; Dismuke-Greer CE Subst Abuse Treat Prev Policy; 2024 Aug; 19(1):39. PubMed ID: 39215320 [TBL] [Abstract][Full Text] [Related]
16. Impulsivity and Medical Care Utilization in Veterans Treated for Substance Use Disorder. Bjork JM; Reisweber J; Burchett JR; Plonski PE; Konova AB; Lopez-Guzman S; Dismuke-Greer CE Subst Use Misuse; 2021; 56(12):1741-1751. PubMed ID: 34328052 [TBL] [Abstract][Full Text] [Related]
17. Interpersonal styles, peer relationships, and outcomes in residential substance use treatment. Harrison AJ; Timko C; Blonigen DM J Subst Abuse Treat; 2017 Oct; 81():17-24. PubMed ID: 28847451 [TBL] [Abstract][Full Text] [Related]
18. High Risk of Substance Use Disorder-Related Outcomes in Veterans Released from Correctional Facilities in Mid to Late Life. Barry LC; Steffens DC; Covinsky KE; Conwell Y; Boscardin J; Li Y; Byers AL J Gen Intern Med; 2023 Apr; 38(5):1109-1118. PubMed ID: 36781577 [TBL] [Abstract][Full Text] [Related]
19. Dissemination of cognitive behavioral therapy for substance use disorders in the Department of Veterans Affairs Health Care System: Description and evaluation of Veteran outcomes. DeMarce JM; Gnys M; Raffa SD; Kumpula M; Karlin BE Subst Abus; 2021; 42(2):168-174. PubMed ID: 31644386 [TBL] [Abstract][Full Text] [Related]
20. Treatment setting and baseline substance use severity interact to predict patients' outcomes. Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]